블로그
- The 20th anniversary 와타리움展 Nam June Paik Next exhibition The 20th anniversary of his passing July 19 (Sun.) - November 23 (Mon.) Paik Exhibition Planting design and construction : GREEN WISE Co.,Ltd.
- 2026.06.23.nippon shinyaku《☆중요☆》 후쿠야마 선천성 근디스트로피 관련 신약 뉴스 granted to NS-035 for the Treatment of Fukuyama congenital muscular dystrophy in Japan KYOTO, Japan, June 23, 2026 - Nippon Shinyaku Co., Ltd.
- The World Cup Opens With Shows Across Three Nations World Cup opened with music, color, and huge crowds across Mexico, Canada, and the United States on June Music, dancing, and colorful co.......
- Meet TIA at Automate 2026! TIA Co., Ltd. will be exhibiting at Automate 2026, North America's largest automation exhibition. Date: June 22–25, 2026 Venue: McCormick Place, Chicago, IL Booth: KIRIA #3684 (KIRIA: Korea Institute
- Else 엘스 (2024), V/H/S Beyond V/H/S 비욘드 (2024)- 부천영화제 Film Review . ☆☆☆ A Les Produits Francaise/Wrong Men/Cine+ OCS Co-Production, in association with CineVerse/Fandor Music: Shida Shahabi, June Ha. Visual Effects: Arnau Leviez. Sound Design: Renaud Bajeux.
- Nvidia CEO는, “저는 모든 사람이 이런 유형의 AI를 사용하기를 권장합니다. 그 AI는 무료이고 당신에게 ‘당신이 좋아하는 것은 무엇이든 가르쳐줄 수 있습니다’”고 말한다 Jensen Huang, co-founder and chief executive officer of Nvidia Corp., during a news conference in Taipei , Taiwan, on Tuesday, June 4, 2024.
- [싱가포르항공]객실승무원채용/마감6월2일 *** Online application is now open until 2 June 2024. from a recognized university -Willing to relocate to Singapore -Willingness and commitment to serve a co
- DAY06 ETS 토익 VOCA 예문 대화문 필수 어휘 (2) + 뜻 있음 연례의 We're planning our annual awards banquet for June for about 100 guests promote v. 홍보하다; 승진시키다 I want to find a way to promote our travel company's bus tours My co-worker was just promoted
- [FDA, 200616] 키트루다, 고형암 환자 대상 허가 고형암 환자 대상 허가 - ORR, DoR (The main efficacy outcome) - ORR 29%, CR 4%, PR 25%. mDoR not reached On June the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co
- [FDA, 200610] 옵디보, 식도편평세포암종 허가 fluoropyrimidine- and pltinum-based 치료 받은 환자 대상 FDA 허가 - OS 개선 (The major efficacy outcome), 2차 지표들은 비슷하거나 불만족 On June 10, 2020, the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for
1 페이지
다음 →